Human Blood Monocyte Receptor Expression and Modulation
Human Blood Monocyte Receptor Expression and Modulation
批准号:
7858333
负责人:
Alan D Schreiber
金额:
$55.57万
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-04-01 至 2011-09-30
关键词:
Antigen-Antibody ComplexAutoimmune DiseasesAutoimmunityBindingBinding SitesC-terminalCell physiologyClathrinClathrin AdaptorsComplexEndocytosisGlycocalyxGoalsHost DefenseHumanITAMImmunoglobulin GLeadLeucineLigandsMediatingMembrane MicrodomainsMolecularMolecular and Cellular BiologyMutationN-terminalOutcomeParticulatePathway interactionsPhagocytosisPlayProcessProteinsRoleTFAP2A geneTyrosineTyrosine PhosphorylationUbiquitinationcrosslinkfunctional outcomeshuman SYK proteinimmune clearanceimmunoregulationmacrophagemonocytereceptorreceptor expressionreceptor mediated endocytosisresponsesrc-Family Kinasesubiquitin ligase
中文摘要
巨噬细胞Fey受体(FcyR)在宿主防御和自身免疫中起重要作用。跟随它们的聚集
英文摘要
Macrophage Fey receptors (FcyR) are important in host defense and autoimmunity. Following their clustering
by IgG complexes, the internalization of macrophage FcyR and their IgG ligand can proceed by several
pathways. Receptor clustering by small IgG aggregates leads to internalization via endocytosis, and
clustering via large particulate complexes (e.g. IgG coated cells) leads to internalization via phagocytosis.
Although both processes involve activation of identical receptors by the same ligand (theFc portion ofIgG),
we have observed profound differences in the molecular mechanisms mediating these internalization
pathways leading to distinct functional outcomes.
For example, the C-terminal tyrosine (Y298), of the FcyRIIA ITAM is critical for optimal phagocytosis, but is
dispensable for endocytosis. By contrast, the N-terminal ITAM tyrosine (Y282) appears essential for both
processes. Also, while phosphorylation of tyrosines in the ITAM by Src family kinases (SRTKs) is an essen-
tial step for initiation of phagocytosis, our evidence indicates that endocytosis is not dependent on receptor
tyrosine phosphorylation by Src kinases, nor does it involve Syk kinase. We have also observed that
ubiquitination is not required for the initial step of FcyRIIA mediated phagocytosis, but is essential for FcyRIIA
mediated endocytosis. Further, mutation of the FcyRIIA Y282XXL leucine (L) (Y282 intact) completely inhibits
endocytosis by FcyRIIA, suggesting that both Y282 and L.285 are required for this process. This observation
argues in favor of interaction of Y282XXL with the clathrin adaptor AP-2as the mechanism underlying
receptor mediated endocytosis, since YXXL motifs have been implicated in clathrin-mediated endocytosis.
Using cellular and molecular biology approaches, we will pursue our long term goal to define the molecular
mechanism(s) underlying Fey receptor mediated endocytosis and phagocytosis. Specifically, we will
determine: 1) if a FcyRIIA sequence constitutes a binding site for AP-2, 2) which ubiquitin ligases are
important in FcyRIIA mediated endocytosis and phagocytosis, 3) the potential role of the inhibitory receptor
Pc/RUB in regulating endocytosis, 4) the role of lipid rafts in FcvRIIA mediated phagocytosis, 5) sequences
responsible for Fc/RIIA lipid raft localization, and finally 6) the role of ubiquitination in phagosomal
maturation. Since Fey receptor mediated phagocytosisand endocytosisof IgG complexes play an important
role in host defense and autoimmune disorders, it is essential to understand the distinct molecular
mechanisms involved in these processes.
期刊论文(56)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Stimulation of macrophage Fc gamma RIIIA activates the receptor-associated protein tyrosine kinase Syk and induces phosphorylation of multiple proteins including p95Vav and p62/GAP-associated protein.
巨噬细胞 Fc gamma RIIIA 的刺激会激活受体相关蛋白酪氨酸激酶 Syk 并诱导多种蛋白的磷酸化,包括 p95Vav 和 p62/GAP 相关蛋白。
DOI:
--
发表时间:
1994
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Darby,C, Geahlen,RL, Schreiber,AD]
通讯作者:
Schreiber,AD
Modulation of Fc gamma receptors on the human macrophage cell line U-937.
人巨噬细胞系 U-937 上 Fc γ 受体的调节。
DOI:
10.1016/0008-8749(89)90185-8
发表时间:
1989
期刊:
Cellular immunology
影响因子:
4.3
作者:
[Rossman,MD, Chen,E, Chien,P, Schreiber,AD]
通讯作者:
Schreiber,AD
Thrombosis and shock induced by activating antiplatelet antibodies in human Fc gamma RIIA transgenic mice: the interplay among antibody, spleen, and Fc receptor.
激活人 Fc γ RIIA 转基因小鼠抗血小板抗体诱导的血栓形成和休克:抗体、脾脏和 Fc 受体之间的相互作用。
DOI:
--
发表时间:
2000
期刊:
Blood
影响因子:
20.3
作者:
[Taylor,SM, Reilly,MP, Schreiber,AD, Chien,P, Tuckosh,JR, McKenzie,SE]
通讯作者:
McKenzie,SE
The monocyte Fcgamma receptors FcgammaRI/gamma and FcgammaRIIA differ in their interaction with Syk and with Src-related tyrosine kinases.
单核细胞 Fcgamma 受体 FcgammaRI/gamma 和 FcgammaRIIA 与 Syk 和 Src 相关酪氨酸激酶的相互作用不同。
DOI:
10.1189/jlb.1103562
发表时间:
2004
期刊:
Journal of leukocyte biology
影响因子:
5.5
作者:
[Huang,Zhen-Yu, Hunter,Sharon, Kim,Moo-Kyung, Chien,Paul, Worth,RandallG, Indik,ZenaK, Schreiber,AlanD]
通讯作者:
Schreiber,AlanD
Characterization of Fc gamma receptors on a human erythroleukemia cell line (HEL).
人红白血病细胞系 (HEL) 上 Fc γ 受体的表征。
DOI:
--
发表时间:
1992
期刊:
Experimental hematology
影响因子:
2.6
作者:
[King,M, Comber,PG, Chien,P, Ruiz,P, Schreiber,AD]
通讯作者:
Schreiber,AD
共 39 条
Biology of the Human Platelet Fc(gamma) Receptor
-
批准号:6741160
-
项目类别:
-
资助金额:$32.33万
-
财政年份:2003
-
负责人:Alan D Schreiber
-
依托单位:
BIOLOGY OF HUMAN PLATELET FC(GAMMA) RECEPTORS
-
批准号:6573409
-
项目类别:
-
资助金额:$19.72万
-
财政年份:2002
-
负责人:Alan D Schreiber
-
依托单位:
Leukocyte Activating Fc Receptors in Immune Lung Injury
-
批准号:6442716
-
项目类别:
-
资助金额:$36.99万
-
财政年份:2001
-
负责人:Alan D Schreiber
-
依托单位:
Leukocyte Activating Fc Receptors in Immune Lung Injury
-
批准号:6528176
-
项目类别:
-
资助金额:$35.53万
-
财政年份:2001
-
负责人:Alan D Schreiber
-
依托单位:
BIOLOGY OF HUMAN PLATELET FC(GAMMA) RECEPTORS
-
批准号:6435892
-
项目类别:
-
资助金额:$19.72万
-
财政年份:2001
-
负责人:Alan D Schreiber
-
依托单位:
Leukocyte Activating Fc Receptors in Immune Lung Injury
-
批准号:6789304
-
项目类别:
-
资助金额:$35.53万
-
财政年份:2001
-
负责人:Alan D Schreiber
-
依托单位:
Leukocyte Activating Fc Receptors in Immune Lung Injury
-
批准号:6616072
-
项目类别:
-
资助金额:$35.53万
-
财政年份:2001
-
负责人:Alan D Schreiber
-
依托单位:
BIOLOGY OF HUMAN PLATELET FC(GAMMA) RECEPTORS
-
批准号:6302218
-
项目类别:
-
资助金额:$30.63万
-
财政年份:2000
-
负责人:Alan D Schreiber
-
依托单位:
BIOLOGY OF HUMAN PLATELET FC(GAMMA) RECEPTORS
-
批准号:6109912
-
项目类别:
-
资助金额:$30.63万
-
财政年份:1999
-
负责人:Alan D Schreiber
-
依托单位:
BIOLOGY OF HUMAN PLATELET FC(GAMMA) RECEPTORS
-
批准号:6272834
-
项目类别:
-
资助金额:$30.43万
-
财政年份:1998
-
负责人:Alan D Schreiber
-
依托单位:
BIOLOGY OF PLATELET FC(GAMMA) RECEPTORS
-
批准号:6241997
-
项目类别:
-
资助金额:$25.0万
-
财政年份:1997
-
负责人:Alan D Schreiber
-
依托单位:
HUMAN BLOOD MONOCYTE RECEPTOR EXPRESSION AND MODULATION
-
批准号:3133035
-
项目类别:
-
资助金额:$31.18万
-
财政年份:1985
-
负责人:Alan D Schreiber
-
依托单位:
HUMAN BLOOD MONOCYTE RECEPTOR EXPRESSION AND MODULATION
-
批准号:3133031
-
项目类别:
-
资助金额:$20.86万
-
财政年份:1985
-
负责人:Alan D Schreiber
-
依托单位:
HUMAN BLOOD MONOCYTE RECEPTOR EXPRESSION AND MODULATION
-
批准号:3133032
-
项目类别:
-
资助金额:$21.05万
-
财政年份:1985
-
负责人:Alan D Schreiber
-
依托单位:
HUMAN BLOOD MONOCYTE RECEPTOR EXPRESSION AND MODULATION
-
批准号:2390286
-
项目类别:
-
资助金额:$34.36万
-
财政年份:1985
-
负责人:Alan D Schreiber
-
依托单位:
BLOOD MONOCYTE RECEPTOR EXPRESSION AND MODULATION
-
批准号:2061746
-
项目类别:
-
资助金额:$32.09万
-
财政年份:1985
-
负责人:Alan D Schreiber
-
依托单位:
HUMAN BLOOD MONOCYTE RECEPTOR EXPRESSION AND MODULATION
-
批准号:2061747
-
项目类别:
-
资助金额:$28.92万
-
财政年份:1985
-
负责人:Alan D Schreiber
-
依托单位:
HUMAN BLOOD MONOCYTE RECEPTOR EXPRESSION AND MODULATION
-
批准号:2671820
-
项目类别:
-
资助金额:$35.73万
-
财政年份:1985
-
负责人:Alan D Schreiber
-
依托单位:
HUMAN BLOOD MONOCYTE RECEPTOR EXPRESSION AND MODULATION
-
批准号:3133034
-
项目类别:
-
资助金额:$29.98万
-
财政年份:1985
-
负责人:Alan D Schreiber
-
依托单位:
HUMAN BLOOD MONOCYTE RECEPTOR EXPRESSION AND MODULATION
-
批准号:6287941
-
项目类别:
-
资助金额:$41.23万
-
财政年份:1985
-
负责人:Alan D Schreiber
-
依托单位:
国内基金
海外基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
-
批准号:31171277
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:Christine Nardini
-
依托单位: